Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors

BACKGROUND: Highly sensitive molecular assays have been developed to detect plasma-based circulating tumor DNA (ctDNA), and emerging evidence suggests their clinical utility for monitoring minimal residual disease and recurrent disease, providing prognostic information, and monitoring therapy respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jianhua, Reuther, Jacquelyn, Scozzaro, Kaylee, Hawley, Megan, Metzger, Emily, Emery, Matthew, Chen, Ingrid, Barbosa, Michelle, Johnson, Laura, O’Connor, Alijah, Washburn, Mike, Hartje, Luke, Reckase, Erik, Johnson, Verity, Zhang, Yuhua, Westheimer, Emily, O’Callaghan, William, Malani, Nirav, Chesh, Adrian, Moreau, Michael, Daber, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590345/
https://www.ncbi.nlm.nih.gov/pubmed/37632661
http://dx.doi.org/10.1007/s40291-023-00670-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590345/
https://www.ncbi.nlm.nih.gov/pubmed/37632661
http://dx.doi.org/10.1007/s40291-023-00670-1

Ejemplares similares